Sun.Aug 05, 2018

article thumbnail

Sensyne Health + Chelsea and Westminster Hospital NHS Foundation Trust sign Strategic Research Agreement for Clinical AI

Lloyd Price

New agreement enables analysis of anonymised patient data using clinical artificial intelligence technology to accelerate medical research, help find new treatments and improve patient care. Sensyne Health Limited (the "Company"), formerly Drayson Health, a British clinical AI technology company, announces today that it has signed a Strategic Research Agreement (SRA) with Chelsea and Westminster Hospital NHS Foundation Trust.

article thumbnail

MARKET SHARE STILL MATTERS: 3 WAYS TO WIN

Henry Kotula

[link]. For CEOs, market share is critical. But measurement of it, and tactics to grow it, are getting more complicated as patients connect with providers in more sophisticated ways. Health system CEOs have always worked to meet their mission of caring for the poor and underserved and improving the health of their community. They often cite that mission as their top priority.

article thumbnail

Biomedical Knowledge Must Be Mobilized to Save Lives, Not Privatized in the “Last Mile”

Society for Participatory Medicine

Guest post by SPM Lifetime Member Joshua C. Rubin, JD, MBA, MPH, MPP. Last week, Facebook’s unprecedented stock price collapse triggered by concerns over personal data privacy, as well as same-day commentary regarding GlaxoSmithKline’s investment in 23andMe to gain access to its customers’ genomic data, reignited a national dialogue vis-à-vis our rights to our data, especially our health data.